Furthermore, the physical interaction of MT5-MMP with APP and increased production of Aβ/C99 also corroborate the idea that the proteinase is a new, full-fledged player in APP metabolism, and hence a potential new target molecule in AD treatment [25,26]. The gene discussed is APP; the disease is Alzheimer disease.